Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02624388 · OUTCOME

Number of Cycles Where Granulocyte-colony Stimulating Factor (G-CSF) is Administered

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) · Source last updated 2024-05-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
cycles
Interval / dispersion
Not reported
Time frame
From the first date study drug is taken until the last date that study drug is taken, about 8 - 12 weeks if there are no chemotherapy delays

Groups in this outcome

Arm A: Genistein Followed by Placebo

Genistein daily throughout chemotherapy cycles 1 and 2, and placebo daily during chemotherapy cycles 3 and 4 Genistein: Estrogen-like compound (isoflavone) derived from soybeans Placebo: Pill that contains no medicine

Arm B: Placebo Followed by Genistein

Placebo daily throughout chemotherapy cycles 1 and 2, and genistein daily during chemotherapy cycles 3 and 4 Genistein: Estrogen-like compound (isoflavone) derived from soybeans Placebo: Pill that contains no medicine

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm A: Genistein Followed by Placebo2
Arm B: Placebo Followed by Genistein2

Analysis denominator · cycles

GroupSource count
Arm A: Genistein Followed by Placebo4
Arm B: Placebo Followed by Genistein4

Reported measurements

Genistein cycles
Values in cycles · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm A: Genistein Followed by Placebo2Not reportedNot reportedNot reportedNot reported
Arm B: Placebo Followed by Genistein0Not reportedNot reportedNot reportedNot reported
Placebo cycles
Values in cycles · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm A: Genistein Followed by Placebo0Not reportedNot reportedNot reportedNot reported
Arm B: Placebo Followed by Genistein0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        2
      2. group Id
        OG001
        value
        0
    title
    Genistein cycles
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        0
    title
    Placebo cycles
denom Units Selected
cycles
denoms
  1. counts
    1. group Id
      OG000
      value
      2
    2. group Id
      OG001
      value
      2
    units
    Participants
  2. counts
    1. group Id
      OG000
      value
      4
    2. group Id
      OG001
      value
      4
    units
    cycles
groups
  1. description
    Genistein daily throughout chemotherapy cycles 1 and 2, and placebo daily during chemotherapy cycles 3 and 4 Genistein: Estrogen-like compound (isoflavone) derived from soybeans Placebo: Pill that contains no medicine
    id
    OG000
    title
    Arm A: Genistein Followed by Placebo
  2. description
    Placebo daily throughout chemotherapy cycles 1 and 2, and genistein daily during chemotherapy cycles 3 and 4 Genistein: Estrogen-like compound (isoflavone) derived from soybeans Placebo: Pill that contains no medicine
    id
    OG001
    title
    Arm B: Placebo Followed by Genistein
param Type
NUMBER
reporting Status
POSTED
time Frame
From the first date study drug is taken until the last date that study drug is taken, about 8 - 12 weeks if there are no chemotherapy delays
title
Number of Cycles Where Granulocyte-colony Stimulating Factor (G-CSF) is Administered
type
SECONDARY
type Units Analyzed
cycles
unit Of Measure
cycles

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice